top of page
Search

ARQon
Jan 82 min read
China: New Updates for Pharmaceutical Excipients and Packaging Materials Appendices to GMP (w.e.f. 1 January 2026)
The State Drug Administration of China has released an important update aimed at strengthening the quality management of pharmaceutical...

ARQon
Dec 10, 20242 min read
China: NMPA Introduces Interim Provisions on Domestic Responsible Persons Designated by Overseas Drug Marketing Authorization Holders (w.e.f 1 July 2025)
To enforce the Drug Administration Law of the People’s Republic of China and the Vaccine Administration Law of the People’s Republic of...

ARQon
Jul 16, 20241 min read
China: NMPA Outlines New Standards for Radiofrequency Therapy Devices (w.e.f 1 April 2026)
On the 2nd of July 2024, the Centre for Medical Device Evaluation (CMDE) announced the clarification by the National Medical Products...

ARQon
May 28, 20241 min read
China: Optimization of Registration Application for Transferring Overseas-Produced Drugs into Domestic Production
As part of the initiative to boost foreign investments in the pharmaceutical industry and improve high-quality drug developments and...
bottom of page